<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0290">
 <label>58</label>
 <element-citation publication-type="journal" id="rf0220">
  <person-group person-group-type="author">
   <name>
    <surname>Sivasankarapillai</surname>
    <given-names>V.S.</given-names>
   </name>
   <name>
    <surname>Pillai</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Rahdar</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Sobha</surname>
    <given-names>A.P.</given-names>
   </name>
   <name>
    <surname>Das</surname>
    <given-names>S.S.</given-names>
   </name>
   <name>
    <surname>Mitropoulos</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Mokarrar</surname>
    <given-names>M.H.</given-names>
   </name>
   <name>
    <surname>Kyzas</surname>
    <given-names>G.Z.</given-names>
   </name>
  </person-group>
  <article-title>On facing the SARS-cov-2 (COVID-19) with combination of nanomaterials and medicine: possible strategies and first challenges</article-title>
  <source>Nanomaterials.</source>
  <volume>10</volume>
  <year>2020</year>
  <fpage>1</fpage>
  <lpage>23</lpage>
  <pub-id pub-id-type="doi">10.3390/nano10050852</pub-id>
 </element-citation>
</ref>
